Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Thrombopoietin receptor agonists combined with intensive immunosuppressive therapy improve outcomes in elderly patients with severe aplastic anemia: A single-center retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBo ShaoQCQin CaoHJHao Jiang

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows improved response rates in elderly patients with severe aplastic anemia using immunosuppressive therapy combined with thrombopoietin receptor agonists.

Key Points

  • Enhanced response rates at 12 months were observed in elderly patients receiving combined immunosuppressive therapy.
  • Overall survival rate at 12 months reached 83.3%, highlighting the effectiveness of treatment strategies.
  • Assessment using a retrospective analysis across elderly patients with severe aplastic anemia and related conditions.
  • These findings suggest the potential of thrombopoietin receptor agonists in enhancing treatment for elderly patients, warranting further studies.

Cite This Study

Shao et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d322https://doi.org/10.1182/blood-2025-1119
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term outcomes of intensive immunosuppressive therapy combined with eltrombopag in patients with severe aplastic anemia2025
  2. 2Clinical outcomes of frontline ATG-based immunosuppressive therapy in older patients with aplastic anemia2025
  3. 3Real-world use of thrombopoietic agents in treatment-naïve children with severe aplastic anemia: a multicenter retrospective study2026
  4. 4Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry2026
  5. 5Outcomes of eltrombopag combined with immunosuppressive therapy in adults with severe aplastic anemia: A large, propensity-matched retrospective analysis2025